Publications by authors named "J M Segrestaa"

Claim this Profile
R
Reversible oxidation/reduction steps in the metabolic degradation of the glycerol side chain of the S1P modulator ponesimod.
Alexander Treiber, Swen Seeland, Jérôme Segrestaa, Cyrille Lescop, Martin H Bolli

Xenobiotica· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, Metabolism, and Excretion of ACT-1004-1239, a First-In-Class CXCR7 Antagonist: , Preclinical, and Clinical Data.
Christine Huynh, Swen Seeland, Jerome Segrestaa, Carmela Gnerre, Jens Hogeback

Front Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-species comparison of the metabolism and excretion of selexipag.
Tomohiko Ichikawa, Tetsuhiro Yamada, Alexander Treiber, Carmela Gnerre, Jérôme Segrestaa

Xenobiotica· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The metabolism and drug-drug interaction potential of the selective prostacyclin receptor agonist selexipag.
Carmela Gnerre, Jérôme Segrestaa, Swen Seeland, Päivi Äänismaa, Thomas Pfeifer

Xenobiotica· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation.
Richard W D Welford, Magali Vercauteren, Annette Trébaul, Christophe Cattaneo, Doriane Eckert, Jérôme Segrestaa

Sci Rep· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis